Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biphasic Insulin Aspart 30 vs Biphasic Human Insulin 30/70 in Diabetes
NCT01467323Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 1998
- Primary completion
- Sep 1998
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of Insulin aspart + insulin aspart protamine in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 1998; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01467323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467323.